Intelligence · Clinical Pipeline
Lakefront Biotherapeutics NV Pipeline
All ClinicalTrials.gov programs at Lakefront Biotherapeutics NV — phase, modality, and trial IDs.
- Programs
- 62
Quick answer
Lakefront Biotherapeutics NV has 62 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
GLPG3667
Lakefront Biotherapeutics NV
Healthy
3 trials -
GLPG3667 capsule
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG3667 oral suspension
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG3970 film-coated tablet
Lakefront Biotherapeutics NV
Systemic Lupus Erythematosus
1 trial -
GLPG3970 film-coated tablet
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG3970 oral solution
Lakefront Biotherapeutics NV
Healthy
2 trials -
GLPG4059 oral suspension
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG4399 oral suspension
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG4716
Lakefront Biotherapeutics NV
Healthy
1 trial -
MOR106
Lakefront Biotherapeutics NV
Healthy
1 trial -
MOR106 single ascending doses, intravenous
Lakefront Biotherapeutics NV
Healthy
1 trial -
Pirfenidone
Lakefront Biotherapeutics NV
Healthy
1 trial -
Sulfasalazine
Lakefront Biotherapeutics NV
Healthy
1 trial -
placebo
Lakefront Biotherapeutics NV
Healthy
1 trial
Frequently asked questions
How many pipeline programs does Lakefront Biotherapeutics NV have?
62 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs